Fig. 2From: A Journey in Science: Immersion in the search for effective cancer immunotherapiesExamples of the earliest complete responses to IL-2 administration that ultimately led to the first FDA approval of a cancer immunotherapy (upper panels, melanoma; lower panels, renal cancer)Back to article page